Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Gynecol Obstet Biol Reprod (Paris) ; 44(3): 230-6, 2015 Mar.
Article in French | MEDLINE | ID: mdl-25661495

ABSTRACT

In the absence of contraindication, methotrexate by intramuscular unique injection of 1mg/kg or 50mg/m(2) is the medical treatment recommended for tubal ectopic pregnancy (EP; LE1). It can be renewed once, at the same dose, according to hCG rates decrease. The pretherapeutic biological assessment contains blood cells numeration, renal and hepatic function. Methotrexate therapy constitutes an alternative conservative treatment to laparoscopic salpingotomy for non-complicated tubal EP (LE1) with hCG level <5000 UI/L (LE2). When the rates of hCG are <1000 UI and or presented a spontaneous decreasing kinetics, the simple prospect (LE2) is preferred. It is recommended to use intramuscular methotrexate in case of surgical conservative treatment failure or more prematurely if the follow-up is not possible (LE3). Except in particular cases there is no indication to use methotrexate in local injection under sonographic control in usual tubal EP (LE2). The use of in situ injection methotrexate is an option to handle the cervical, interstitial or on caesareans scar pregnancies (LE2). In front of a persistent undetermined location pregnancy, after more than 10 days of survey, in an asymptomatic woman and/or at rate of hCG >2000 UI/L, the systematic treatment by methotrexate is an option. The methotrexate is not indicated for first trimester termination of pregnancy or miscarriage neither in placentas accreta nor in association with other treatments such myfegine or potassium.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Evidence-Based Medicine/standards , Gynecology/standards , Methotrexate/administration & dosage , Obstetrics/standards , Off-Label Use/standards , Pregnancy, Ectopic/drug therapy , Female , Humans , Pregnancy
2.
Gynecol Obstet Fertil ; 35(2): 121-4, 2007 Feb.
Article in French | MEDLINE | ID: mdl-17223605

ABSTRACT

We report ultrasonographic features of interstitial pregnancy and propose three magnetic resonance imaging criteria for the interstitial pregnancy localization. These criteria may facilitate the differentiation between an interstitial pregnancy and an angular pregnancy. The magnetic resonance imaging may be used whenever ultrasound examination diagnosis of an interstitial pregnancy is equivocal.


Subject(s)
Magnetic Resonance Imaging/methods , Pregnancy, Ectopic/diagnosis , Ultrasonography, Prenatal/methods , Abortifacient Agents, Nonsteroidal/therapeutic use , Adult , Female , Humans , Methotrexate/therapeutic use , Pregnancy
3.
Ann Fr Anesth Reanim ; 25(6): 644-7, 2006 Jun.
Article in French | MEDLINE | ID: mdl-16701977

ABSTRACT

Pelvic pain during pregnancy and postpartum period is common. Pubic separation is a physiologic phenomenon caused by pregnancy and delivery. It's an aetiology of pregnancy and postpartum pain requiring a specialized management in case of severe pain. We report the case of a 34-year-old multiparous woman suffering from severe pubic symphysis pain after twin delivery by vaginal approach, with extraction support, under epidural analgesia. Pubic symphysis separation was diagnosed according both to the clinical symptoms and to the radiology. A local anesthetic infiltration was performed twice to substantially relieve the patient.


Subject(s)
Extraction, Obstetrical , Pelvic Pain/etiology , Pregnancy, Multiple , Pubic Symphysis/physiopathology , Adult , Analgesia, Epidural , Analgesia, Obstetrical , Analgesics, Opioid/therapeutic use , Anesthetics, Local/administration & dosage , Female , Humans , Lidocaine/administration & dosage , Nerve Block , Pelvic Pain/drug therapy , Pregnancy , Pubic Symphysis/diagnostic imaging , Radiography , Twins
4.
Gynecol Obstet Fertil ; 34(2): 101-6, 2006 Feb.
Article in French | MEDLINE | ID: mdl-16442326

ABSTRACT

OBJECTIVE: To evaluate the results of laparoscopic surgery in the management of ovarian cysts in pregnant patients. PATIENTS AND METHODS: Retrospective study including 26 pregnant patients who underwent the laparoscopic management of ovarian cysts. The indications for surgery were persistent adnexal mass, abnormal ovarian cysts revealed by ultrasound examination, suspicion of cyst complications. The technique used, the immediate postoperative results and obstetrical outcomes were studied. RESULTS: Twelve patients were operated during the first trimester of pregnancy, 13 in the second, and one in the third trimester. A 12 mmHg CO2 pneumoperitoneum was created, using a Veress needle in 22 cases, and an open technique in 4 cases. Trocar sites were decided according to the uterine size and to the cyst situation. A cystectomy was performed in 11 cases, an adnexectomy in 7 cases, an oophorectomy in one case, a cyst aspiration with a biopsy of the cyst wall in 6 cases and an ovarian torsion removal in one case. A conversion to laparotomy was necessary in 3 cases. There were no immediate postoperative complications and obstetrical outcomes were good in all cases. DISCUSSION AND CONCLUSION: In pregnant patients, laparoscopic management of adnexal masses appears to be safe for both mother and child.


Subject(s)
Laparoscopy/methods , Ovarian Cysts/surgery , Pregnancy Complications/surgery , Pregnancy Outcome , Adult , Female , Humans , Infant, Newborn , Postoperative Complications/epidemiology , Pregnancy , Retrospective Studies , Torsion Abnormality/surgery
5.
Gynecol Obstet Fertil ; 33(10): 768-71, 2005 Oct.
Article in French | MEDLINE | ID: mdl-16139555

ABSTRACT

The prolapse of a uterine tube is a rare event after hysterectomy with adnexal conservation. It is described in the literature after abdominal or vagina hysterectomy. We report two cases occurring after laparoscopic hysterectomy, and complicated by pyosalpingitis. Patients have presented with pelvic pain and vaginal discharge. Diagnosis was not easy, clinically suspected with the transvaginal ultrasonography, and confirmed by celioscopy. It may be helped by biopsy. The laparoscopic management was carried out without complications.


Subject(s)
Hysterectomy/adverse effects , Salpingitis/etiology , Adult , Diagnosis, Differential , Fallopian Tube Diseases/diagnosis , Fallopian Tube Diseases/etiology , Fallopian Tube Diseases/surgery , Female , Humans , Laparoscopy , Middle Aged , Prolapse , Salpingitis/diagnosis , Salpingitis/surgery , Treatment Outcome
7.
J Gynecol Obstet Biol Reprod (Paris) ; 29(6): 564-70, 2000 Oct.
Article in French | MEDLINE | ID: mdl-11084463

ABSTRACT

OBJECTIVES: To evaluate the place of ovarian transposition by laparoscopy in an effort to preserve ovarian function without compromising oncological safety among young women requiring intravaginal brachytherapy before surgery for cervical cancer. MATERIAL AND METHODS: The series was represented by 20 cases, all FIGO stage I squamous cell malignant diseases of the cervix. Mean age: 32 years (range 23-40). Oophoropexy (7 instances) or lateral high ovarian transposition (13 instances) was performed by laparoscopy, just before brachytherapy using cesium 137. RESULTS: Continued hormonal function was achieved in 58% of the available cases, 50% (3/6) after oophoropexy, 68% (8/11) after ovarian transposition. Mean follow-up was 8.5 years (range 5-13). The mean radiation dose absorbed by the displaced ovary was 2.6 Gy (range 1. 2-5.9). CONCLUSION: Ovarian transposition through laparoscopy before brachytherapy should be advised for selected stage I squamous type malignant tumor size 2 cm without lymphatic/vascular channel invasion by neoplastic emboli and without lymph node involvement. This procedure has been abandoned in our institution, instead of this, primary surgical treatment is accomplished (laparoscopically-assisted vaginal) radical hysterectomy is associated with orthotopic ovarian conservation.


Subject(s)
Brachytherapy , Carcinoma, Squamous Cell/radiotherapy , Laparoscopy , Ovary/surgery , Uterine Cervical Neoplasms/radiotherapy , Adult , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Cesium Radioisotopes/therapeutic use , Female , Humans , Neoplasm Staging , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...